Thermo Fisher Scientific Inc. ( NYSE: TMO) Wolfe 2024 Healthcare Results Conference November 19, 2024 8:00 AM ET Marc Casper - Chairman, President and Chief Executive Officer ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...
Formalin fixed paraffin embedded (FFPE) patient tumor specimens are readily accessible and established gold standard for ...
One of the categories for the Awards is the Best CRO Award, which NJ Bio co-shared with PPD, Inc., a subsidiary of Thermo Fisher Scientific ... network in Charleston, SC, as part of a $12.5 million, ...
PPD FSP solutions, part of the PPDâ„¢ clinical research business of Thermo Fisher Scientific, helps clients create all manner of flexible outsourcing solutions, many of which are detailed in ...
Explore the latest pharmaceutical validation developments with industry experts from Barry-Wehmiller Design Group, Kneat Solutions, and No Deviation. You’ll gain valuable data-driven insights and ...
Separately, the company on Tuesday said it has entered into an agreement with Thermo Fisher Scientific to collaborate on obtaining US Food and Drug Administration approval for their co-branded kidney ...
Boston, USA-headquartered essential equipment and chemicals supplier to pharmaceutical industry Thermo Fisher Scientific is setting up a bioprocess design centre (BDC) at Genome Valley ...
John Tlumacki / The Boston Globe via Getty Images Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled. The maker of lab ...
Thermo Fisher told investors it is ready to shut the door on 2024, anticipating biotech funding to improve and lingering business insecurity caused by the … ...